CSIMarket
 


Voyager Therapeutics Inc   (VYGR)
Other Ticker:  
 


Voyager Therapeutics Inc 's Operating Profit Margin by quarter

Trends, Rankings, Statistics



VYGR Operating Profit Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change - -88.77 % 581.6 % 22769.3 % -
Seq. Revenue Change 1851.91 % -4.92 % -96.77 % - -
Revenue In Millions $90.06 $4.61 $4.85 $150.48 $-1.55
Operating Profit Margin 60.03 % -639.51 % -523.92 % 81.66 % -
Operating Profit Margin Total Ranking # 184 # # # 78 #
Operating Income In Millions $54.06 $-29.51 $-25.43 $122.88 $-24.56
Y / Y Operating Income Change - - - - -
Seq. Operating Income Change - - - - -


Commenting fourth Quarter 2023 Operating Profit Margin
Voyager Therapeutics Inc achieved Operating Income of $54 millions compare to Operating Loss of $-29.51 millions recorded in previous quarter. Revenue increased by 1851.91 % Company accomplished above average Operating Profit Margin with 60.03 %.

Observing fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry Voyager Therapeutics Inc has achieved highest Operating Profit Margin. While Operating Profit Margin overall ranking has deteriorated compare to previous quarter from to 184.
Explain Operating Margin
VYGR's Operating Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 8
Overall # 184

Operating Profit Margin Statistics
High Average Low
81.66 % 48.14 % 19.94 %
(Mar 31 2023)   (Jun 30 2019)




Other Operating Profit Margin Profitability Ratios
VYGR's Cumulative Operating Profit Margin
Biotechnology & Pharmaceuticals Industry Operating Profit Margin Trends and Statistics
Healthcare Sector Operating Profit Margin Statistics
Operating Profit Margin Profitability Trends for overall market
VYGR's Operating Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Profit Margin
Lowest Ranking Operating Profit Margin
Operating Profit Margin Profit Margin for VYGR's Competitors
Operating Profit Margin Profit Margin for Voyager Therapeutics Inc 's Suppliers
Operating Profit Margin Profit Margin for VYGR's Customers

You may also want to know
VYGR's Annual Growth Rates VYGR's Profitability Ratios VYGR's Asset Turnover Ratio VYGR's Dividend Growth
VYGR's Roe VYGR's Valuation Ratios VYGR's Financial Strength Ratios VYGR's Operating Income Growth
VYGR's Roa VYGR's Inventory Turnover Ratio VYGR's Growth Rates VYGR's Dividend Comparisons


Companies with similar Operating Profit Margin in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Operating Profit MarginDec 31 2023 MRQ Operating IncomeDec 31 2023 MRQ Revenue
Voyager Therapeutics Inc   60.03 %$ 54.063 $ 90.061 
Halozyme Therapeutics Inc   43.92 %$ 101.035 $ 230.039 
Neurocrine Biosciences Inc   29.17 %$ 150.300 $ 515.200 
Biogen Inc   24.21 %$ 577.700 $ 2,386.300 
Gilead Sciences Inc   22.66 %$ 1,612.000 $ 7,114.000 
Qiagen N v   21.57 %$ 409.938 $ 1,900.688 
Vericel Corporation  19.59 %$ 12.731 $ 64.996 
Adma Biologics Inc   19.06 %$ 14.233 $ 74.686 
Biontech Se  18.08 %$ 773.248 $ 4,277.280 
Exelixis Inc   17.05 %$ 81.788 $ 479.652 
Amgen Inc   15.51 %$ 1,271.000 $ 8,196.000 
Bio techne Corp  13.94 %$ 38.004 $ 272.587 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com